Skip to main content

Disease management

By Emily Olsen | 01:09 pm | April 26, 2022
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
By Emily Olsen | 11:15 am | April 26, 2022
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
By Emily Olsen | 01:23 pm | April 22, 2022
However, researchers found that participants' tendencies toward anxiety or pain catastrophizing affected which intervention worked better.
By Adam Ang | 12:36 am | April 22, 2022
Also, Intuitive India releases its mobile app for surgeons using the da Vinci RAS system.
By Emily Olsen | 01:49 pm | April 20, 2022
Also: Virtual ketamine therapy company Nue Life Health brings in $23 million in Series A and debt financing, and Source Health launches out of stealth with a $3 million seed.
By Dr. Spencer Dorn | 10:22 am | April 15, 2022
Dr. Spencer Dorn, gastroenterologist, professor and vice chair of medicine for care innovation at the University of North Carolina, writes on the potential for innovation to change gastroenterology care. 
By Emily Olsen | 03:04 pm | April 13, 2022
Also: Pear Therapeutics receives FDA SteP designation for its product candidate focused on acute and chronic pain, and Carbon Health launches its diabetes management program.
By Adam Ang | 03:52 am | April 13, 2022
The digital platform enables clinicians to adjust their patient's devices remotely and in real-time.
By Emily Olsen | 02:36 pm | April 04, 2022
Patients work with dietitians to build meal plans and have ingredients delivered to their homes.
By Adam Ang | 05:19 am | March 29, 2022
The BUZUD smartwatches can also measure blood oxygen levels, blood pressure, and heart rate.